PearlDx is pleased to announce that the United States Patent and Trademark Office issued US Patent Application Pub. No. 20200225224 as US Patent No. 11,079,380 on Aug. 3, 2021. The issued claims relate to optimization of diagnostics for galactofuranose containing antigens.